An Australian law firm is investigating a class action against drug manufacturers over a commonly prescribed antibiotic said to cause “disabling” side effects, including nerve damage and psychosis.
Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.
Monash IVF is gearing up for a legal privilege fight as it faces new claims about the team of senior doctors and directors working on a novel testing technique at the heart of a class action, including claims that one doctor “burnt paper evidence” from a trial of the technology.
Sanofi has lost its bid to limit evidence from experts for Amgen in a patent dispute over a cholesterol-lowering antibody, with a judge dismissing concerns about Amgen having a majority of experts giving concurrent evidence. In an application filed at the beginning of the month, the French pharmaceutical company sought to bar Amgen from relying…
A former top judge appointed to decide the first-ever contest to administer a class action settlement has set out his criteria for making the choice, and has warned that giving the firm running a case a monopoly right to dole out the proceeds could lead to higher costs for group members and poorer settlement outcomes.
The first healthcare provider to be found liable in one of several underpayments class actions by junior doctors is challenging a ruling that found permission to work overtime hours did not have to be expressly given.
Indian generic drug maker Cipla has sued pharmaceutical giants Bristol-Myers Squibb and Pfizer alleging the patents behind their blockbuster deep vein thrombosis drug Eliquis are invalid.
Sydney-based plastic surgeon Daniel Lanzer, who is facing a class action by 1,000 former patients, has been hit with a new lawsuit alleging he performed a negligent liposuction and fat transfer procedure, which left a woman with disfigurement, necrosis and nerve damage.
The runner-up in a contest to administer Johnson & Johnson’s $300 million settlement of two pelvic mesh class actions has lost a challenge to a decision awarding the prize to the team of Slater & Gordon, BDO and the firm of former Shine Lawyers solicitor Jan Saddler.
A group of surgeons who worked for The Cosmetic Institute are appealing a judge’s rejection of their bid to declass a representative proceeding on behalf of 13,500 patients who claim they suffered injury or complications from breast augmentation surgery.